$HTO

47,030 Shares in H2O America $HTO Purchased by E. Ohman J or Asset Management AB

E. Ohman J or Asset Management AB has acquired a new stake of 47,030 shares in H2O America (NASDAQ:HTO), valued at approximately $2,306,000, according to its latest SEC filing. This purchase makes the institutional investor own about 0.13% of the utilities provider. Other institutional investors also made significant share purchases in H2O America during recent quarters.

Original reporting
MarketBeat · MarketBeat
Published Mar 25, 2026, 8:25 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Mar 25, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
47,030 Shares in H2O America $HTO Purchased by E. Ohman J or Asset Management AB — source image
Decision brief

The 30-second read

$HTOBullishMed
01

Why it matters

The purchase by E. Ohman J or Asset Management AB suggests confidence in the company's prospects, which could lead to short-term price appreciation.

02

Market read

The news indicates a positive institutional sentiment towards H2O America, with potential short-term trading opportunities.

03

What to watch

Lack of recent earnings data, technical analysis, and broader market conditions could influence stock performance independently of institutional activity.

Relevance 6/10Timing: Immediate to short-term (next 1-3 months)

Background

Recent SEC filings reveal increased institutional ownership in H2O America, a utility sector company, indicating potential positive sentiment.

Company-level read

Ticker impact

$HTOBullishMedium confidence
Context

High relevance due to recent institutional purchase indicating potential positive sentiment.

Expected impact

Moderate upward price movement expected over the next 1-3 months.

Evidence & confidence

While institutional buying can indicate positive sentiment, the relatively small ownership stake (0.13%) and lack of recent price action data limit the certainty of this prediction.

Market effects

Potential positive sentiment in the utilities sector due to increased institutional confidence in H2O America.

Limited regional impact; specific to US utilities sector.

Negligible; sector-specific news with minimal global influence.

Counterpoint

Institutional buying may be opportunistic rather than indicative of long-term growth; potential for short-term price bump without sustained fundamentals.

Key entities

  • H2O America

    A utility sector company listed on NASDAQ.

  • E. Ohman J or Asset Management AB

    An asset management firm that recently acquired shares in H2O America.

Related articles

$HTOMed

H2O America Completes Texas Subsidiary’s Acquisition of Quadvest

H2O America (HTO) completed its Texas subsidiary's acquisition of Quadvest, doubling its water and wastewater connections in Texas. The deal is expected to increase Texas customers to 26% of the company's total by 2029, up from 8%. Quadvest's operations and team will be integrated into H2O America's Texas Water Company, enhancing its utility portfolio and reducing risk exposure.

$HTOMed

H2O America Announces Second Quarter 2026 Financial Results

H2O AMERICA (HTO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991-2q2026.htm EX-99.1 Document EXHIBIT 99.1 H2O America Announces Second Quarter 2026 Financial Results • Second quarter 2026 reported diluted EPS of $0.62 and adjusted diluted EPS (non-GAAP) 1 of $0.72, as compared to reported and adjusted diluted EPS in the se

$REGNMed

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

Regeneron Pharmaceuticals reported initial trial results for ubamatamab, showing a 73% objective response rate and 11-month median progression-free survival in 11 patients with advanced low-grade serous ovarian cancer (LGSOC). The company plans to advance the drug into a Phase 3 trial and discuss the data with the FDA. LGSOC is a rare form of ovarian cancer with limited treatment options.

$HDBMed

HDFC Bank’s new CEO Anup Bagchi: From ICICI to the top job

Anup Bagchi, with over 30 years of experience in banking and financial services, has been appointed as the new MD and CEO of HDFC Bank. He previously held senior roles at ICICI Group, including CEO of ICICI Prudential Life Insurance and Executive Director at ICICI Bank. Bagchi's leadership at ICICI Bank included growing retail mortgage loans and managing operations during demonetization.